Nonprofit · EIN 38-2117115
EVERSIGHT
Tax-exempt · ANN ARBOR, MI 48108
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $34,039,876 | $30,603,995 | $3,435,881 | $48,487,446 | $22,914,001 | $25,573,445 |
| December 31, 2023 | 990 | $30,662,355 | $27,526,933 | $3,135,422 | $45,849,022 | $23,048,867 | $22,800,155 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $1,166,781
- Program service revenue
- $30,572,532
- Investment income
- $2,281,435
- Net gain from sales of assets
- $1,661,763
- Net income from fundraising events
- $19,128
- Other revenue
- $19,128
Expenses
- Grants and similar amounts paid
- $60,000
- Compensation of officers, directors and key employees
- $1,454,566
- Other salaries and wages
- $9,596,333
- Salaries, compensation and benefits (total)
- $14,610,374
- Professional fundraising fees
- $0
- Legal fees
- $16,537
- Accounting fees
- $120,152
- Occupancy
- $1,517,845
- Travel
- $177,244
- Depreciation
- $252,773
- Program services (functional)
- $24,289,326
- Management and general (functional)
- $5,672,481
- Fundraising (functional)
- $642,188
Balance sheet and other
- Total assets, start of year
- $45,849,022
- Total assets, end of year
- $48,487,446
- Total liabilities, end of year
- $22,914,001
- Net assets, end of year
- $25,573,445
- Land, buildings and equipment
- $6,143,870
- Publicly traded securities
- $14,042,529
- Net assets without donor restrictions
- $25,444,203
- Net assets with donor restrictions
- $129,242
- Gross receipts
- $48,995,418
- Employees
- 187
- Volunteers
- 64
- Year formed
- 1986
- State of legal domicile
- MI
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| Diane Hollingsworth | President & CEO Officer | 50 | $302,974 | $34,437 |
| Michael Titus | Sr. VP, Clinical Services Officer | 50 | $218,538 | $34,243 |
| Julie Collins | Chief Finance & Administrative Officer Officer | 50 | $215,850 | $29,609 |
| Michael O'Keefe | Chief Operations Officer Officer | 50 | $209,314 | $29,609 |
| Bret Hopman | SR. VP, Marketing & Communications Officer | 50 | $165,861 | $32,569 |
| Onkar Sawant | VP, Research & Innovations Officer | 50 | $168,441 | $13,111 |
| Catherine McClory | Director, Compliance & Quality Assurance Highest-paid employee | 50 | $157,251 | $12,724 |
| Indu Vadakkepattath | Data Scientist/Applications Manager Highest-paid employee | 50 | $150,320 | $12,134 |
| Caitlin Lopes | Partner Relations Director Highest-paid employee | 50 | $126,027 | $33,249 |
| Joseph Zullo | Manager, Information Technology Highest-paid employee | 50 | $114,985 | $16,481 |
| Kara Kelley | Partner Relations Director Highest-paid employee | 50 | $109,886 | $9,468 |
| Patty Jo Herndon | Imm. Past Chair Trustee or director, Officer | 1 | $0 | $0 |
| Kathy L Zelenock | Chair Trustee or director, Officer | 1 | $0 | $0 |
| Joseph M Maiuri | Treasurer Trustee or director, Officer | 1 | $0 | $0 |
| Mahmoud N Ghazzi MD PhD | Secretary Trustee or director, Officer | 1 | $0 | $0 |
10 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Lorenzo Cervantes MD | Director Trustee or director | 1 | $0 |
| Jonathan Lass MD | Director Trustee or director | 1 | $0 |
| Shahzad Mian MD | Director Trustee or director | 1 | $0 |
| Carol Cunningham MD | Director Trustee or director | 1 | $0 |
| Probi Kapur | Director Trustee or director | 1 | $0 |
| Carolyn M Welsh | Vice-Chair Trustee or director | 1 | $0 |
| Sandra Fletcher | Director Trustee or director | 1 | $0 |
| Peter Wroblewski | Director Trustee or director | 1 | $0 |
| Jill Maher MA COE | Director Trustee or director | 1 | $0 |
| John Ryan | Director Trustee or director | 1 | $0 |
990 for the year ended December 31, 2023: 24 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| DIANE HOLLINGSWORTH | PRESIDENT & Officer | 50 | $264,097 | $68,580 |
| JULIE COLLINS | CFO Officer | 50 | $224,333 | $59,953 |
| MICHAEL O'KEEFE | COO Officer | 50 | $219,990 | $59,407 |
| MICHAEL TITUS | VP CLINICAL Officer | 50 | $178,075 | $60,169 |
| BRET HOPMAN | VP MARKETING Officer | 50 | $153,446 | $51,732 |
| ONKAR SAWANT | DIR. RESEARC Highest-paid employee | 50 | $158,673 | $31,465 |
| CATHERINE MCCLORY | DIR. COMPLIA Highest-paid employee | 50 | $146,074 | $31,631 |
| INDU VADAKKEPATTATH | DATA SCI. & Highest-paid employee | 50 | $142,932 | $31,526 |
| CAITLIN LOPES | DIR. PARTN. Highest-paid employee | 50 | $111,233 | $46,323 |
| KARA KELLY | DIR. PARTN. Highest-paid employee | 50 | $106,022 | $23,602 |
| PATTY JO HERNDON | CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| KATHY L ZELENOCK | VICE CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| DANIELLE E D'ARCY | TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| MAHMOUD N GHAZZI MD PHD | SECRETARY Trustee or director, Officer | 1 | $0 | $0 |
| JAROLD ANDERSON | IMM. PAST CH Trustee or director | 1 | $0 | $0 |
| LORENZO CERVANTES MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JONATHAN LASS MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| SHAHZAD MIAN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| CAROL CUNNINGHAM MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| SANDRA FLETCHER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| PROBI KAPUR | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOSEPH RADTKA | DIRECTOR Trustee or director | 1 | $0 | $0 |
| CAROLYN M WELSH | DIRECTOR Trustee or director | 1 | $0 | $0 |
| PETER WROBLEWSKI | DIRECTOR Trustee or director | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 3985 RESEARCH PARK DR, ANN ARBOR, MI 48108-2219
- Principal officer (990 for 2024)
- Brian Roberts, 3985 Research Park Drive, Ann Arbor, MI 48108
- Signed the 990
- Brian Roberts, Chief Financial Officer
- Phone
- (800) 247-7250
- Website
- www.eversightvision.org
- Return prepared by
- YEO & YEO PC
Mission
Eversight's mission is to restore sight and prevent blindness through the healing power of donation, transplantation and research. Blinding eye diseases affect 80 million Americans. That means millions of people cannot see their loved ones, drive to work or read the newspaper on a Sunday morning. Their vision loss results in an economic impact of $51.4 billion every year in the United States alone. Eversight envisions a world without blindness-a world where all mothers can see their children and all children can grow up to lead independent, productive lives through the gift of sight. To make vision a reality for all, Eversight continuously works to expand its reach, connect more effectively with communities in need and provide the gift of sight to everyone.
Program accomplishments
- RESORING SIGHT Eversight continues to take meaningful steps toward transforming the future of vision care by supporting sustainable eye banking infrastructure and providing priceless clinical education. In 2024, Eversight provided the gift of sight to more than 10,200 people across the United States and around the world. Eversight provided 59 corneas for sight-restoring transplants gratis or at a reduced fee for uninsured patients.Eversight's work began in 1947 with the establishment of the fourth eye bank in the United States, then known as the Illinois Eye-Bank. Over time, nonprofit eye banks were established in every state to meet the critical demand for corneal tissue to treat preventable blindness.In 1985, the Illinois Eye-Bank and Michigan Eye-Bank formed a partnershipone that would earn a reputation for clinical excellence made possible by some of the finest medical directors, staff and board members in the eye banking field. The success of the organization attracted affiliations with other regional eye banks forming one of the largest networks of eye banks in the U.S. In 2015, the network became known as Eversight, all working together as a unified operation to deliver the highest quality services to surgeons and their patients and to continue to grow our impact around the world.Eversight provided more than 14,900 tissues for transplantation, research and education globally in 2024. We worked or placed tissue with physicians and researchers in 34 countries and facilitated training for 918 clinicians. Together with all our partnersadvocates, donor families, transplant recipients, surgeons, Lions, fellow eye banks, healthcare leaders, philanthropic supporters and many otherswe were able to make vision a reality for more people worldwide.Expenses $23,033,157 · revenue $28,388,552
- FINDING A CURE In the pursuit of eliminating blinding eye diseases, Eversight established the Eversight Center for Vision and Eye Banking Research in Cleveland, Ohio, to provide leading ophthalmology researchers with the resources they need to find cures and treatments for eye diseases such as age-related macular degeneration, diabetic retinopathy and glaucoma. Eversight provided more than 4,700 tissues for research and education purposes in 2024. Our in-house research team also provided Eversight partners with valuable research and development services and pioneered new eye banking practices.Since 2014, the Eversight researchers have authored 50 publications and given 34+ presentations at international conferences. The team published six publications in 2024 on: comparing cornea storage medias, perceptions of cornea and eye donation, automated counting and density of donor endothelial cells, protocol for corneal stromal stem cell cultivation, using trypan blue for cell viability after preloading DMEK grafts, and docosahexaenoic acid in diabetic humans and mice. With our many academic partners, Eversight researchers have contributed to over 250 peer-reviewed scientific papers that have garnered 6,300 citations and counting.Eversight has a longstanding track record of research and development, having awarded more than $4 million in grants to date that stimulate pioneering clinical and basic science research aiming to develop new ways to restore sight, prevent blindness and ultimately help patients live life to the fullest. Since 1980, our Eye & Vision Research Grant Program has supported researchers at leading academic medical institutions including Harvard, Tufts, Cleveland Clinic, Case Western Reserve, University of Michigan, Northwestern and more. By design, Eversight's grant program provides critical, early-stage funding that is intended to drive foundational research and discovery. Many of these projects have stimulated larger-scale studies and won further financial support from the National Institutes of Health.In the 2025 funding cycle, Eversight awarded four grants at Loyola University Chicago, University of Houston, University of Illinois Chicago and University of Michigan to advance studies to investigate developing a novel drug evaluation system to stimulate blood vessel growth experimentally using factors that have been linked to the pathophysiology of both wAMD and PDR; enhancing limbal stem cell preservation; understanding the biomechanics of keratoconus by looking at the composition and microstructure of normal human and keratoconus corneal extracellular matrix; and advancing therapies for ocular surface squamous neoplasia. Each year, recipients are selected by an independent review panel of academic researchers and ophthalmologists. This distinguished panel awards proposals that encourage meaningful scientific inquisition and align with Eversight's mission to restore sight and prevent blindness through the healing power of donation, transplantation and research.Expenses $193,609 · grants $60,000 · revenue $75,664
- SUSTAINABLE INTERNATIONAL IMPACTEversight works to eliminate corneal blindness worldwide through eye bank development, clinical training and tissue provision. With more than 75 years of eye banking expertise, we deliver both short- and long-term solutions to transform the lives of more than 12 million people suffering from corneal blindness globally. In 2024, Eversight International provided more than 4,200 tissues for transplant and worked with surgeons in 33 countries outside the United States, making the gift of sight possible for many in need. Eversight provided 76 cornea tissues for sight-restoring transplants gratis or at a reduced rate for medical missions and uninsured patients outside the United States.In medically underserved areas, Eversight Global Development fosters authentic relationships with local leaders to establish culturally informed eye donation frameworks and sustainable eye banking infrastructure. Our experienced team offers vital clinical training and education to eye surgeons and eye bank technicians on the latest clinical methods, improving access to life-changing transplants. Through the incredible generosity of our donors and donor families, Eversight Global Development also provides corneal tissue from the United States for transplant and research globally, providing hope for the future and restoring sight to patients in need. Our global mission is informed by and aligns with the United Nations Sustainable Development Goals (SDGs), with particular attention given to: #3 Good Health and Well-being, #4 Quality Education, #8 Decent Work and Economic Growth, #10 Reduced Inequalities and #11 Sustainable Cities & Communities. According to the World Health Organization, every dollar spent on improving eye health in underdeveloped areas generates a four-fold return on investment. To address systemic unmet need, Eversight actively works with medical professionals, governments, vision health organizations and other NGOs in regions lacking eye banks and infrastructure, including United Arab Emirates, Pakistan and South Korea. With proven eye banking and technical training practicesand having played a part in the elimination of the U.S. cornea transplant waiting listEversight is uniquely qualified to work with countries lacking transplant programs to help them establish national networks for eye banking and cornea donation with culturally appropriate donation models and state-of-the-art clinical capabilities.Globally, an estimated 2.2 billion people are impacted by blindness and visual impairment. Ninety percent of vision-impaired people live in low- and middle- income countries. Approximately one billion of these individuals are coping with blindness or visual impairment that can be characterized as preventable or not sufficiently addressed. Vision loss results in substantial economic impact worldwide due to the inability of people who are vision impaired to contribute to their fullest in their communities. Eversight envisions a world without blindnessa world where all people in every community can lead independent, productive lives through the gift of sight. While providing for immediate global cornea transplant needs with U.S. donor tissue, Eversight continues to address the global burden by empowering international communities to take meaningful, sustainable steps every day to make vision a reality for all.Expenses $1,062,560 · revenue $2,108,316
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 38-2117115
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1976
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Assets (IRS master file)
- $48,487,446
- Income (IRS master file)
- $48,995,418
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $34,039,876 | $30,603,995 | $48,487,446 | XML |
| 990 | December 2023 | $30,662,355 | $27,526,933 | $45,849,022 | XML |
| 990 | December 2022 | $25,488,101 | $24,016,038 | $41,527,985 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2019 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 38-2117115).
Questions about EVERSIGHT
- What is the EIN of EVERSIGHT?
- The employer identification number (EIN) of EVERSIGHT is 38-2117115.
- Is EVERSIGHT tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1976.
- Are donations to EVERSIGHT tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does EVERSIGHT file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of EVERSIGHT due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did EVERSIGHT last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of EVERSIGHT?
- The 990 for the year ended December 31, 2024 names Brian Roberts.
- Who are the officers and directors of EVERSIGHT?
- The 990 for the year ended December 31, 2024 lists 25 people; 11 received compensation from the organization, the highest $302,974 (Diane Hollingsworth, President & CEO).
- How much revenue does EVERSIGHT have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $34,039,876, expenses of $30,603,995 and total assets of $48,487,446 at year end.
Other nonprofits in ANN ARBOR
- IHA HEALTH SERVICES CORPORATION EIN 38-3316559 · last filed 990 for 2025
- NATIONAL CENTER FOR MANUFACTURING SCIENCES EIN 38-2761126 · last filed 990 for 2024
- NSF INTERNATIONAL EIN 38-1428955 · last filed 990 for 2024
- NATIONAL ADVANCED MOBILITY CONSORTIUM EIN 26-2571197 · last filed 990 for 2025
- ORGAN PROCUREMENT AGENCY OF MICHIGAN EIN 38-2772488 · last filed 990 for 2025
- CREDIT UNIONS CHARTERED IN THE STATE OF MICHIGAN EIN 38-1464920 · last filed 990 for 2025
- UNIVERSITY CORPORATION FOR ADVANCED INTERNET DEVELOPMENT EIN 52-2060187 · last filed 990 for 2024
- HOSPICE OF MICHIGAN INC EIN 38-2255529 · last filed 990 for 2024